BioMed Realty Trust Inc

Most Recent

  • uploads///C P FFO
    Company & Industry Overviews

    BioMed Realty Is Trading at a Discount Compared to Peers—For Now

    A close look at BioMed Realty’s TTM price-to-FFO ratio shows that the company is in line with its historical valuation. Its current ratio is ~16.3x.

    By Peter Barnes
  • uploads///C DEBT
    Company & Industry Overviews

    What’s Funding BioMed Realty’s Acquisitions?

    At the end of 2014, BioMed Realty’s consolidated debt was $2.7 billion. Its total debt rose from $1.5 billion in 2010 to $3 billion as of September 2015.

    By Peter Barnes
  • uploads///C FFO PAYOUT
    Company & Industry Overviews

    Analyzing BioMed Realty’s Higher FFO Payout Ratio

    Bolstered by higher FFO per share, BioMed Realty increased its dividend by 36.5% to $1.31 per common share in 2014—its highest dividend in seven years.

    By Peter Barnes
  • uploads///C OCCU
    Company & Industry Overviews

    Higher Demand Likely to Drive BioMed Realty’s Occupancy in 2016

    The improving economy, favorable business fundamentals, and a focus on life science companies have led to strong demand for BioMed Realty’s properties.

    By Peter Barnes
  • uploads///C BLACKSTONE
    Company & Industry Overviews

    So Why Is Blackstone Acquiring BioMed Realty?

    In October 2015, Blackstone agreed to acquire all BioMed Realty’s outstanding shares of common stock for $23.75 per share—an $8 billion transaction.

    By Peter Barnes
  • uploads///C STRATEGY
    Company & Industry Overviews

    BioMed Realty’s Other Strategy: Generating Sustainable Growth

    BioMed Realty’s growth strategy aims to meet demands for specialized office and laboratory space by leveraging its local knowledge and management expertise.

    By Peter Barnes
  • uploads///C EV EBITDA
    Company & Industry Overviews

    Interpreting BioMed Realty’s EV-to-EBITDA Multiple

    A close look at BioMed Realty Trust’s EV-to-EBITDA multiple shows that its ratio is in line with its historical valuation, with a current ratio of ~14.8x.

    By Peter Barnes
  • uploads///c acqui
    Company & Industry Overviews

    BioMed Realty’s Property Acquisitions Have Been Enhancing Its Portfolio Quality

    Many companies are looking to acquire properties in BioMed Realty’s core markets, thus enhancing competition for strategic properties.

    By Peter Barnes
  • uploads///C TENANT
    Company & Industry Overviews

    BioMed Realty’s Quality Tenant Base and Triple Net Leases Ensure Steady Cash Flows

    BioMed Realty’s tenant base has the top names in biotechnology companies, scientific research institutions, governments, and other life science firms.

    By Peter Barnes
  • uploads///C Dev
    Company & Industry Overviews

    BioMed Realty’s Strategy: Adding Value through Property Development and Redevelopment

    BioMed Realty focuses on value creation through development and redevelopment of old and new properties, aiming to develop space on all land it acquires.

    By Peter Barnes
  • uploads///C PROP
    Company & Industry Overviews

    An Overview of BioMed Realty’s Specialized Property Portfolio

    BioMed Realty’s total property portfolio witnessed increased from 12.2 million square feet in 2010 to 17.5 million square feet in 2014.

    By Peter Barnes
  • An Investor’s Introduction to BioMed Realty Trust
    Company & Industry Overviews

    An Investor’s Introduction to BioMed Realty Trust

    BioMed Realty is now the fifth-largest publicly traded office REIT in the United States and is a part of the S&P 400 Index.

    By Peter Barnes
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.